Posts Tagged ‘least-squares (LS)’:

A Comparison of the pharmacokinetics of foretinib free base tablet formulation to bisphosphate salt capsule formulation for solid tumors.

Naing A, Kurzrock R, Adams LM, Kleha JF, Laubscher KH, Bonate PL, Weller S, Fitzgerald C, Xu Y, Lorusso PM. “Invest New Drugs. 2010 Sep” Purpose: This phase I, open-label, randomized, 2-part crossover research assessed the security, pharmacokinetics and relative bioavailability of single doses of the anticancer Met inhibitor foretinib (previously known as GSK1363089, EXEL-2880

(Read More…)

© Apoptosis|apoptosis inhibitor|apoptosis pathway
CyberChimps